Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CCDC134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BLOC1S2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTBD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY86-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADRA1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCA9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGPTL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHST8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEFB125 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on